Medtronic PLC
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
213 / 663
Position in country
95 / 187
Return on Assets, %
4.6
-11.9
Net income margin, %
16.5
-12.5
EBITDA margin, %
28
-2.5
Debt to Equity, %
48.6
15
Intangible assets and goodwill, %
60.3
3.9
Revenue CAGR 3Y, %
2.5
12.6
Total Equity change 1Y, %
0.6
0
Revenue Y, % chg
5
4.6
P/E
25.4
28.3
P/BV
2
1.7
P/S
3.2
3.7
EV/S
3.8
3.2
EV/EBITDA
13.1
-0.2
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
19.1
66.5
Forward P/E
14.7
19.2
Dividend Yield, %
3.4
1.8
Forward Dividend Yield, %
3.5
0.2
Expected dividend per share
2.8
0
Payout Ratio, %
87
17.3
Dividend Ex Date
2024-03-21
Competitors
Ranks
-
Dexcom Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Medtronic PLC
00%
-
Edwards Lifesciences Corp
00%
-
Siemens Healthineers AG
00%
-
Abbott Laboratories
00%
-
STERIS plc
00%
-
Becton Dickinson and Co
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Ireland; Republic of
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
106398.4
Ticker
MDT.N
ISIN
IE00BTN1Y115
IPO date
1977-11-21
Availability on Russian exchanges
Yes
Reporting for
2024-02-27
Date fact. publication of reports
2024-01-26
Company Description
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: